WebJun 17, 2024 · Tenaya is advancing a pipeline of therapeutic candidates, including several adeno-associated virus (AAV) gene therapies, for the potential treatment of both rare and … WebSep 8, 2024 · Tenaya Therapeutics reported business and program updates and second quarter 2024 financial results. ... statements regarding Tenaya’s pipeline of product candidates, including TN-201 and TYA ...
Tenaya talks inhouse capabilities for CGT firms - BioProcess ...
WebAug 10, 2024 · Received State Licensing to Enable cGMP Manufacturing of Drug Product TN-201 and TN-301 IND Submissions on Track for Second Half 2024 Presented Preclinical Data for Multiple Pipeline Programs and ... WebTenaya Overview Advancing a Pipeline of Novel Therapeutics to Address the Underlying Causes of Heart Disease for Both Prevalent and Orphan Indications 100% FOCUSED ON HEART DISEASE •Addressing... include bleed
Tenaya Therapeutics Reports Second Quarter 2024 Financial
WebApr 12, 2024 · South San Francisco, CA -- April 12, 2024 --. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data for its approved and investigational medicines will be highlighted in 30 abstracts at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which … WebIn preclinical studies, Tenaya’s HDAC6 inhibitors have been shown to increase cardiac function, reduce inflammation and fibrosis, reverse diastolic dysfunction and improve … As Tenaya’s General Counsel, Ms. Drimmer brings a wealth of experience in legal … Tenaya is using biological insights from our team and our collaborators to discover … Our name, Tenaya, represents who we are and what we believe in. Inspired by the … Tenaya Therapeutics 171 Oyster Point Blvd., Suite 500 South San Francisco, … WebSOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver... inc international flat sandals